United States Biotechnology & Medical Research

Eikon Therapeutics Inc (EIKN)

Track

Eikon Therapeutics Inc. saw significant insider buying activity in early February 2026. Multiple entities, including Column Group IV GP, LP, Kenneth C. Frazier, and Lux Venture Partners V, LLC, executed substantial purchase transactions. The most recent trading activity occurred on February 6, 2026, with no further insider transactions reported in the last three months.
Ticker: EIKN
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 6 Feb 2026
Value US$111,780.34 | Price 443.21 | Shares 56,127 (+13.5%)
Buy 6 Feb 2026
Value US$4,605,213.41 | Price 305.64 | Shares 69,727 (+27.1%)
Buy 6 Feb 2026
Value US$25,871,814.00 | Price 18.00 | Shares 1,437,323 (+50.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-09 2026-02-06 B Purchase
Column Group IV GP, LP
Large shareholder
56,127 +13.5%
443.21
US$111,780 		56,127 +13.5% 443.21 US$111,780
2026-02-09 2026-02-06 B Purchase
Column Group IV GP, LP
Large shareholder
69,727 +27.1%
305.64
US$4,605,213 		69,727 +27.1% 305.64 US$4,605,213
2026-02-09 2026-02-06 B Purchase
Column Group IV GP, LP
Large shareholder
52,271 -39.0%
264.15
US$3,033,212 		52,271 -39.0% 264.15 US$3,033,212
2026-02-06 2026-02-04 B Purchase
2.1
Foresite Capital Management IV, LLC
Large shareholder
55,555 +4.4%
18.00
US$999,990 		55,555 +4.4% 18.00 US$999,990
2026-02-06 2026-02-04 B Purchase
2.9
FRAZIER KENNETH C
Non-Executive Director
111,111 +inf%
18.00
US$1,999,998 		111,111 +inf% 18.00 US$1,999,998
2026-02-06 2026-02-04 B Purchase
0.5
Lux Venture Partners V, LLC
Large shareholder
138,888 +inf%
18.00
US$2,499,984 		138,888 +inf% 18.00 US$2,499,984
2026-02-06 2026-02-04 B Purchase
0.5
Lux Venture Partners V, LLC
Large shareholder
138,888 +inf%
18.00
US$2,499,984 		138,888 +inf% 18.00 US$2,499,984
2026-02-06 2026-02-04 B Purchase
0.5
Wolfe Josh
Non-Executive Director Large shareholder
138,888 +inf%
18.00
US$2,499,984 		138,888 +inf% 18.00 US$2,499,984
2026-02-06 2026-02-04 B Purchase
0.5
Wolfe Josh
Non-Executive Director Large shareholder
138,888 +inf%
18.00
US$2,499,984 		138,888 +inf% 18.00 US$2,499,984
Explore more

More insider trading research around Eikon Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America